0.0600
-0.0050
(-7.69%)
At close: January 10 at 3:57:08 PM EST
Breakdown
TTM
10/31/2023
10/31/2022
10/31/2021
10/31/2020
Operating Cash Flow
-848.7680
-1,054.8480
-1,574.6090
-5,294.4260
-1,226.8850
Investing Cash Flow
--
--
--
--
61.3640
Financing Cash Flow
2,394.0090
917.1000
1,108.2450
3,438.9860
3,354.6080
End Cash Position
489.3000
0.9770
141.8980
593.1150
2,423.0950
Issuance of Capital Stock
2,413.6130
917.1000
1,108.2450
3,060.2340
2,973.0320
Repayment of Debt
--
--
--
-369.7000
--
Free Cash Flow
-1,905.1320
-1,054.8480
-1,574.6090
-5,294.4260
-1,226.8850
10/31/2020 - 11/27/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LOBE.CN Lobe Sciences Ltd.
0.0250
0.00%
LWB.SG Mesoblast Ltd
1.6200
0.00%
QPT.V Quest PharmaTech Inc.
0.0250
0.00%
ASEP.CN ASEP Medical Holdings Inc.
0.0500
0.00%
DOSE.CN Rapid Dose Therapeutics Corp.
0.2250
-6.25%
MDMA.CN Pharmala Biotech Holdings Inc.
0.3100
+16.98%
XRTX.V XORTX Therapeutics Inc.
1.8500
-5.13%
GBLX GB Sciences, Inc.
0.0040
+11.11%
BCT.TO BriaCell Therapeutics Corp.
0.5900
-3.28%
HEM.V Hemostemix Inc.
0.2400
+20.00%